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Abstract
This article presents highlights chosen from research that appeared during
2016 on Tourette syndrome and other tic disorders. Selected articles felt to
represent meaningful advances in the field are briefly summarized.
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Introduction
This is the third yearly article in the Tourette syndrome Research
Highlights series, intended to share and comment on scientific and
clinical advances on Gilles de la Tourette syndrome (TS) and other
tic disorders. The highlights from 2017 article is being drafted on
the Authorea online authoring platform, and readers are encouraged to add references or give feedback on our selections using
the comment feature on that page. After the calendar year ends, the
article is submitted as the annual update for the Tics collection on
F1000Research.

Methods
A PubMed search was conducted using the search strategy “(“Tic
Disorders” [MeSH] OR Tourette NOT Tourette[AU]) AND
2016[PDAT] NOT 1950:2015[PDAT]”. On 06 Jan 2017, this search
returned 186 citations, none of which had first appeared in 2017.
The author also identified articles or news from other sources, such
as colleagues, email lists, and professional meetings. The studies
cited below were selected subjectively, but guided by a personal
judgment of their potential importance to the field.

Results
Phenomenology and natural history
Epidemiology. A large, population-based health survey was
explored to determine the rate of medically diagnosed TS in
Canada1. One in 1,000 respondents had been diagnosed with TS,
with the rate higher in youth (0.60%, vs. 0.09% in adults), and
in males (risk ratio 5.31). Importantly, those diagnosed with TS
had lower total education, income and employment. The results
must be interpreted in light of the fact that many people with TS
remain undiagnosed, or do not receive medical care.
Environmental effects on tic severity. Environmental effects
on tics are typical in TS; they are included in the Diagnostic
Confidence Index2 and have been demonstrated under careful
laboratory conditions3,4. However, typical patient and clinician
understanding of TS depends largely on self-report and parental
symptom report. Two reports from 2016 highlight some surprising results from prospective observation. First, in one experimental design, tics became less frequent during a short-term
psychosocial stressor5. This finding is counterintuitive given the
daily experience of patients and observations of clinicians, and
supports further research in this area.
Barnea and colleagues recorded video from 41 children age
6–18 with TS in each of five common, daily-life situations6. Their
findings were illuminating. First, tic frequency correlated only
moderately with reports of children or parents. Self-reported premonitory urges were stronger when patients were more aware
of their observed tics. Tic frequency was much higher when
children were watching TV and much lower when alone, compared
to doing homework, receiving attention when ticcing, or talking
to a stranger. The results in the previous sentence differ from
typical reports to clinicians, and suggest that developing methods
for tic monitoring outside the office may be important to
improve reliability and ecological validity in TS research.

Tic suppression. Previous studies have attempted to address
TS as a generalized failure of action inhibition, but that conceptualization may cast the net too wide7–9. A 2013 publication from
Wylie et al.10 had suggested some deficit in response inhibition
(action stopping) in TS. In 2016, the group reported a new study
in young adults with TS, now better controlled for comorbidity11.
Although TS and control groups showed similar speed of cued
movement and vocalization, the tic group was slower at stopping
these responses.
Sensory phenomena. Many patients with TS describe sensory
symptoms preceding or independent of their tics. One group
recently took a new approach to studying sensation in TS based on
a Theory of Event Coding12. Their results suggested that details or
features of percepts are less integrated in TS; this finding applied to
the group as a whole rather than relating to any obvious symptom or
demographic characteristic. The authors speculate as to the possible
underlying neurobiology.
Premonitory urges. Premonitory urges are usually reported
later in life than tics are first observed. However, a large case
series (N>1000) from one clinic suggests that premonitory urges
“emerge much earlier than previously thought”: by age 8–10,
>60% of children reported premonitory urges, and >75% could
suppress tics13. Urges also “were found to be highly associated
with ‘not just right experiences’.” The early onset of tic suppression is consistent with a report from the author’s laboratory on tic
suppression in the first few months of tic disorder onset14.
Brandt et al.15 performed a careful experiment to investigate the
timing of urges in relation to tics, compulsions and—as a comparison to a naturally arising urge—blinks when attempting to
keep the eyes open. Another group examined tics and urge to tic at
10- to 15-second intervals in 12 patients with moderate to severe
TS; different patients had quite different relationships between
urge and tic timing when examined at this temporal scale16. These
observations show that careful phenomenological studies still
have much to teach us about tic disorders.
Other. The frequency of anxiety and impulsivity in TS has
suggested the possibility of a deficit in emotional self-regulation
in some patients. A recent study examined specific emotional
regulation approaches taken by adults with TS17. The TS and
control groups did not differ on anxiety or depression symptom
scores, but the TS group used suppression as a strategy more often
than the control group.
Self-injurious behavior (SIB) is an important clinical problem
in the minority of TS patients who experience it18. Sambrani
et al.13 felt that their data supported lumping SIB with
coprophenomena, and argue for it to “be conceptualized as
a complex tic rather than a compulsion.” Others have found
similar results19, though other results support a connection to
compulsions20, one large study found SIB to fit better with
ADHD symptoms21, and another linked it to both OCD and
ADHD22.
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Self-reported depressive symptoms were as common and severe in
TS as in tic-free patients with major depression, though people with
TS endorsed irritability more frequently23.

Etiology
Genetics. An important, collaborative study showed that rare
copy number variants (CNVs) increase the risk for TS24,25. This
was true both generally for large CNVs, exceeding 1 million base
pairs, and for CNVs previously linked to pathology. Specifically,
NRXN1 and CNTN6 each conferred a substantially increased risk
of TS: 20-fold and 10-fold, respectively. These associations give
important impetus to research focusing on the cellular effects of
these genes and perhaps related treatments. This research also
confirms that the clear genetic risk for TS is spread across numerous genes, because only 1% of patients with TS carry risk alleles in
these two genes.
A population-based adult twin study of tics, ADHD and OCD
found that the co-occurrence of tics and OCD can be partly
explained by shared etiological influences26. The same is true to
some extent for tics and ADHD. Another report concluded that
social disinhibition in TS is heritable27. More research examining
sub-dimensions of these phenotypes may clarify the situation.
Another potentially useful approach to TS genetic research was
illustrated by 28, who sequenced candidate genes suggested by
previous research in order to identify potential functional variants
linked to TS.
Environmental risk factors and epidemiology. Identifying
specific environmental risk factors for TS is important in its own
right, and also because controlling for known environmental
risks can improve the power of genetic studies. Previous studies
have linked TS with lower birthweight, and more recently with
maternal smoking during gestation29–31. Leivonen et al. reported
the first nationwide pseudo-prospective (i.e., based on a Finnish
national health registry) study of prenatal maternal smoking and
TS32. In this sample, the hypothesized association of maternal
smoking with TS per se was not significant, but maternal
smoking during pregnancy was significantly associated with
combined TS and ADHD, and the odds ratio for TS+ADHD
following first trimester smoking was 4.0 (95% CI 1.2–13.5,
p=.027). This association provides only modest support for the
link between prenatal toxicity and TS. However, this study is
consistent with the idea shared by many tic experts that the
current nosology artificially separates tics from other common
symptoms in people with TS.

Pathophysiology
Animal models. A face-valid animal model of tics has been a
very important but elusive goal33. McCairn and colleagues have
now published their important work characterizing a nonhuman
primate tic model34. Temporary unilateral disinhibition of the
nucleus accumbens (NA)—the ventral, more limbic-connected
part of the striatum—produces vocalizations in monkeys that
resemble vocal tics in human patients. The vocalizations sometimes were associated with local field potential (LFP) spikes in

the NA, but not always; in the absence of local LFP spikes, phase
coupling in the alpha frequency band between NA, anterior
cingulate and primary motor cortex tended to be stronger. By
contrast, disinhibition of the (more traditionally motor) dorsolateral putamen led to repetitive movements that the authors call
“myoclonic tics,” whose phenomenology is less similar on its
face to that of tics, and which were regularly preceded by LFP
spikes.
Vasoactive intestinal peptide-expressing interneurons were
targeted for developmental injury using a conditional expression
model in mice35. These mice showed hyperactivity and altered firing of some cells at the onset of the transition from quiescence
to locomotion. How this may relate to lower numbers of parvalbumin-containing interneurons in TS36 is unclear. An interesting
contrast based on the parvalbumin data is provided by a model
in which fast-spiking interneurons in the dorsal striatum were
ablated37. These mice developed anxiety and increased frequency
of grooming rituals.
In another rodent model, D1CT-7 mice—in which dopamine
D1 receptors are targeted— were compared to wild-type mice38.
Spatial confinement triggered stress reflected by corticosterone release in both groups, but exacerbated abnormal behaviors
in the D1CT-7 mice, such as digging, biting, jumping and motor
perseveration. Stress also led to impaired prepulse inhibition,
thought of as reflecting sensorimotor gating. Both the abnormal
motor behavior and the prepulse inhibition deficit improved with
clonidine, haloperidol, or SCH23390 (a dopamine D1 receptor
antagonist). Collectively, these results support the potential utility
of this model in screening new treatments for tic disorders.
Finally, spontaneously-occurring models of tics in other animals
are of great interest39. Kalueff and colleagues provide a helpful
review of the substantial body of knowledge available about
stereotyped grooming patterns in rodents40, arguing appropriately
that these patterns may be “useful for understanding the neural
circuits that are involved in complex sequential patterns of action”
in human disease, including in TS41.
Electrophysiology. In contrast to findings from previous studies
in older patients, resting motor threshold and variability of motor
evoked potential responses in 17 TS subjects, age 12–22, were
increased versus controls, while the gain of motor excitability was
reduced42. The authors suggest that these findings may relate to
delayed maturation of the cortical-cortical and corticospinal motor
networks in TS.
Local field potentials (LFP) in the posterolateral globus pallidus
pars interna (GPi) were recorded at rest and during tics and normal voluntary movements in three adults with TS during deep
brain stimulation surgery and compared to GPi LFP recordings
in four Parkinson disease patients off medication43. Tics were
associated with increased gamma (35–200 Hz) and high frequency (200–400 Hz) activity, and with cross-frequency coupling
(between the phase of beta band activity and the amplitude of the
high-frequency oscillations).
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Negative reinforcement learning is a key variable in theories of
behavior therapies proven effective for TS. In this context, the findings of a 2016 report from Nottingham, England, are interesting.
Behavioral and event-related potential data were collected during
the learning of stimulus-response pairs using positive or negative
reinforcement44. Participants included children age 9–17 with TS,
ADHD, both or neither. Lower accuracy and smaller P3 amplitudes
were observed in association with ADHD, but not TS.
O’Connor and colleagues have developed a cognitive-behavioral
therapy approach to tic treatment, discussed below in the Treatment section, based in part on electrophysiological findings. For
instance, previous studies had identified a reduced P300 oddball
effect in TS patients with or without OCD. This group has now
reported a study of event-related potentials in adults with TS or a
body-focused repetitive behavior disorder (such as trichotillomania) in comparison to a healthy control group45. The P300 oddball
effect was lower in both patient groups before treatment, and
increased with cognitive-psychophysiological treatment.
Neuroimaging studies. A structural brain MRI study in 103
children with TS, age 7–17 years, and 103 matched control subjects, found greater gray matter volume in TS in the posterior
thalamus, hypothalamus and midbrain, and decreased white matter
volume in orbital prefrontal and anterior cingulate cortex46.
Structural abnormalities in these regions was hypothesized to
influence somatosensory processing, decision making or reinforcement learning. Eddy and colleagues continued their research
using theory of mind (ToM) approaches to TS, reporting on
an fMRI study involving a task that required the subject to infer
another person’s thoughts when making decisions47. TS subjects
showed overall lower responses to the ToM task and to a control
task, but also in several regions a lower increase with the ToM
task compared to the control task. These regions included the
posterior cingulate, right angular gyrus and right amygdala,
regions involved in previous ToM studies in people without
tics. Group differences correlated with various symptom severity
measures, including a strong correlation of task-related temporoparietal junction activation with premonitory urge severity.
SPECT imaging with a perfusion marker was used to investigate the possible mechanism of action of deep brain stimulation
in the internal GPi and in the medial thalamus48. Controls included
sham stimulation in the TS group and unstimulated subjects
without tics. Active stimulation in either site decreased regional
blood flow in basal ganglia and cerebellum and increased perfusion
to the frontal cortex, including the supplementary motor area.
Brain imaging studies include very large data sets, and have
required development of novel statistical methods. LessovSchlaggar et al. argued thoughtfully that typical statistical
analyses of a single variable at a time may be inadequate to
find many important solutions to “complex disorders of brain
development and function”, such as TS49.
Pharmacological studies. German researchers reported a fascinating study in 37 medication-free adults with TS and 36 controls

using magnetic resonance spectroscopy (MRS)50. The study tested
the hypothesis that GABA, glutamine (Gln) and glutamate (Glu)
concentrations in striatum and thalamus would differ in people
with TS. Glutamine, Gln+Glu and the Gln:Glu ratio were lower
in TS, more so in the striatum than in the thalamus. The striatal
Gln concentration correlated negatively with tic severity on the day
of the scan, and thalamic Glu concentration correlated negatively
with premonitory urge severity. Surprisingly, these abnormalities
tended to improve during treatment with aripiprazole. The authors
work hard to minimize any effects of head motion, which might
otherwise confound these results. The results overall suggest an
abnormality in glutamatergic transmission in TS. Readers who are
not MRS gurus may benefit from examining their Supplementary
Figure 5, which demonstrates the challenges in eking out signal for
these compounds.
Gremel et al.51 present data from an optogenetic study in mice,
showing that removing cannabinoid type 1 (CB1) receptors from
orbitofrontal cortex efferents to dorsal striatum prevents the mice
from graduating from intentional to habitual lever pressing. The
authors conclude that this cannabinoid-modulated orbitofrontalstriatal pathway is essential to the development of habits.
As tics may be conceptualized as involving overenthusiastic
habit formation circuitry, one might have expected the opposite
result, given anecdotal beneficial short-term effects of cannabinoids on tic severity52.
In another mouse model, knocking out the histamine H3
receptor impaired prepulse inhibition, and abolished or reduced
dopaminergic signaling via both D1 and D2 receptors53. These
results, combined with previous studies linking histamine to TS,
support the development of histamine H3 receptor ligands for
possible use in TS.
Clinical and neuropsychological studies. Thresholds for externally applied sensory stimuli were similar in adults with “pure”
TS and controls54. These results, like those of a previous study55,
demonstrate that the sensory symptoms of TS are central in
origin, suggesting abnormalities in interoceptive awareness or
central sensorimotor processing.
One interesting study focused on the clue that classic features of
TS include echopraxia and suggestibility (the triggering of a tic by
discussing or seeing it). Following up on their previous work56,57,
Münchau and colleagues asked tic-free human control participants
to imitate separately a tic and another, non-tic facial movement
from a matched participant with TS58. While doing so, subjects
watched video of one of the two movements. For non-tic movements, TS subjects responded like controls, in that movements
were performed more quickly when the video was congruent with
the requested movement than when it was incongruent. However,
when asked to execute a tic, TS subjects responded equally quickly
regardless of the video content. The authors conclude that “tic-like
movements do not occur as a consequence of a failure to inhibit
motor output. Instead, tics might be considered highly overlearned
behavior that can be triggered without interference by external,
incompatible movement stimuli.”
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Most adults with TS feel that at least some of their tics are an
eventual voluntary capitulation to an almost irresistible urge,
though some tics are felt to be more truly involuntary. Researchers from Paris reported an interesting study of how adults with TS
judge agency (the sense that one initiates and causes one’s own
actions)59. The study involved manipulating in several different
ways whether a participant’s hand movements were accurately
reflected in the movements of a computer cursor. Those with TS
recognized when their intended movements were substantially
altered, yet were less aware that their intentions had been altered
when the alterations comprised enhancement of their performance. These results add to a prior study of agency in adolescents
with TS, in which awareness of their intention to move was
earlier in those with greater tic suppression ability and later in
those with more severe premonitory urges60. Together, these studies suggest that the sense of agency with intentional movement
differs subtly in people with TS, and may relate to patients’
judgments of whether their tics are volitional.

Treatment
A meta-analysis of tic treatment discusses patient satisfaction in
addition to efficacy and side effects, and concludes that there is
good evidence supporting a favorable benefits:harms ratio for the
most commonly used medications, but that “larger and betterconducted trials addressing important clinical uncertainties are
[still] required”61.

conditions has become more popular, and pilot studies have
appeared applying this approach to tics65,66. In this setting, Gev
et al.67 report their study of 45 children and adolescents with TS
who rated severity of tic urges, and were observed, during each of
three 2-minute conditions: baseline (ticcing freely), tic suppression,
and urge acceptance. Urges and discomfort decreased significantly
during the acceptance condition, and more importantly, so did tic
frequency. By contrast, tic urge intensity and self-rated discomfort increased during the tic suppression condition. These findings
suggest that acceptance therapy may be better—accepted—by
patients. It is now ripe for tests of long-term efficacy.
For some years, O’Connor, Leclerc and colleagues have developed and utilized a cognitive-behavioral-psychophysical treatment
model for tic disorders. The treatment aims to address sensorimotor function more broadly, including proprioception, response
inhibition and perfectionism, rather than focusing on tics directly.
In 2016, several important publications from their group addressed
this approach, including an open study of 102 adults with a
chronic tic disorder68, in which tic severity improved for both simple and complex tics, and the improvement remained at 6 months.
Measures of self-esteem and perfectionism also improved. A pilot
study in children age 8–16 was also reported69, followed by initial results with a manualized version of this therapy in children
age 8–1270. This “cognitive-psychophysiological treatment” model
provides another potential approach to treatment that may prove to
have more generalizable benefits.

Psychological interventions. Behavior therapy is now an accepted
first-line treatment for tic disorders. Still, some practitioners
retain misconceptions about its safety. A report on 228 participants in randomized controlled trials (RCTs) of Comprehensive
Behavioral Intervention for Tics (CBIT) helps to confute those
concerns62. Specifically, CBIT participants were no more likely
to have new tics, have adverse events, increase tic medications or
have an exacerbation in psychiatric symptoms relative to patients
who received supportive therapy.

Medication. An open-label, rater-blind, 8-week study of deutetrabenazine in TS provided positive results71. This compound is
a deuterium-substituted tetrabenazine (a VMAT2 inhibitor) with
slower elimination half-life, and was approved by the U.S. Food
and Drug Administration (FDA) in 2017 as a treatment for chorea
in Huntington disease, making it potentially available for off-label
use for tics. Similarly, another VMAT 2 inhibitor, valbenazine, was
approved in 2017 for treatment of tardive dyskinesia.

Factors that slow wider implementation of behavior therapies
for tics include cost and a limited number of trained practitioners. Group (rather than individual) therapy is one option that
could address these obstacles. A small study provided initial testing of this possibility using a treatment and a control group. Both
groups had improvements in quality of life, and the greatest
improvements in motor tic severity occurred in the HRT group63.
The most important conclusion from this pilot study was that the
group format was acceptable and appears not to impair efficacy.

Adding to prior evidence of anti-tic efficacy, a prospective, open
case series in 44 adults with TS found that aripiprazole helped
non-tic symptoms as well as tics, though premonitory urges to
tic were not significantly improved72. However, in May 2016,
the FDA warned that aripiprazole can cause disinhibition in the
form of impulse control disorders73. Similar side effects have been
described for levodopa and dopamine agonists, but had not been
recognized for aripiprazole, which is a partial agonist at dopamine
receptors.

Another potential solution to the implementation concerns noted
above is providing therapy online. Müller-Vahl and colleagues
are beginning a large RCT that will test the efficacy of CBIT
delivered by internet64. A commercial CBIT delivery system has
been described, but (as of mid-2017) is not yet active.

Other medication trials reported in 2016 include a failed add-on
RCT with N-acetyl-cysteine74 and a case series suggesting iron
supplementation may improve tics in TS patients with low serum
ferritin75.

Research continues on other psychotherapy approaches. Suppressing tics is generally uncomfortable—leading to the theory
of negative reinforcement that motivates CBIT and exposure
and response prevention approaches to tic treatment—and in
recent years Acceptance and Commitment Therapy for various

Neurosurgery. Surgery is an option for carefully selected patients
with TS, yet several important questions remain76. The Galeazzi
Institute in Milan, Italy, provided a progress report on their large
sample of TS patients treated with deep brain stimulation (DBS),
mostly in the ventromedial thalamus77. In 11 of 48 patients (23%),
the device was removed after “inflammatory complications” or
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poor compliance with follow-up. In the remaining 37 patients, 29
had a more than 50% reduction in YGTSS scores (clinician-rated
tic severity and impairment). In a separate publication, they argued
that the patient’s symptoms beyond tics should be considered when
a DBS target is selected78. Hartmann argued contrariwise that our
current state of knowledge better supports a narrower focus on tic
reduction in choosing a DBS target79.
The TS group from Maastricht, The Netherlands, reported positive unblinded follow-up results in five patients with refractory
TS treated with DBS in the anterior GPi80, and a Chinese group
reported unblinded 1-year follow-up of GPi DBS in 24 patients
with TS, with improvement, on average, in both tics and OCD
symptoms (50% reduction in mean YGTSS total tic score and
27% reduction in mean Y-BOCS score; Supplementary File 1)81.
Interestingly, this latter report includes one patient whose tics
continued to improve after the DBS electrode was removed
(p. 1025), consistent either with spontaneous improvement over
time or with a micropallidotomy lesion effect.
DBS in a mouse model suggests that self-injurious behaviors, probably over-represented in TS patients referred for surgery, may be
amenable to DBS of the subthalamic nucleus82.
Given the current lack of consensus on DBS methods in TS,
gathering data on all DBS patient outcomes in TS is crucial, and
a recent collaborative report described the establishment of the
International Deep Brain Stimulation Registry and Database for
Gilles de la Tourette syndrome83.

one’s nosological viewpoint) on social relationships and quality of life in TS87. Wadman and colleagues performed an in-depth
study of 35 youth with TS, their parents, and school personnel
to understand what problems TS caused at school88. Their
conclusion will seem sadly familiar to TS patients and clinicians: “Young people and parents agreed more strongly with each
other than they did with staff regarding school difficulties faced
by individuals, and staff generally reported fewer TS-related
difficulties.”

Additional reference sources
The first Frontiers Research Topic on TS was published this year,
including over 30 articles on TS, many stemming from the 2015
conference in London89. Thenganatt and Jankovic provided a
useful review of TS90. A comprehensive review of Provisional Tic
Disorder also appeared91; this diagnosis refers to children whose
first tic was less than a year ago, similar to Transient Tic Disorder
in earlier nosologies. A helpful overview of TS genetics92, and a
review of epigenetic mechanisms and how they may prove to affect
TS, both appeared in mid-201693.

Conclusions
Advances in many areas of TS research and clinical care were
reported in 2016. Smaller pilot studies remain important for purposes other than settling a question: they can be useful for testing
feasibility, for improving methods, and for identifying new hypotheses. (In fact, one of the most significant publications in TS history
was a single-blind N-of-1 study94.) Several of the studies mentioned
above are small studies that fulfill one or more of these goals.

Other treatment. Many patients have reported to their doctor that
music performance reduces their tic symptoms. Brown84 addressed
this formally, surveying 183 musicians diagnosed with TS. On
a scale of 1 (drastic symptom worsening) to 5 (drastic symptom
improvement), subjects reported a mean of 4.45 for the effect of
engaging in a musical activity (performance, not passive listening).
This result strongly supports the patient anecdotes and suggests that
formal music therapy could be tested in a randomized controlled
trial for benefit on TS symptoms.

Nevertheless, as the title of the 2016 Frontiers Research Topic
suggests, TS research is beginning to grow from case series and
small pilot studies into finding “new avenues through large-scale
collaborative projects.” This change is important, especially in
light of increasing recognition that reproducibility is an important
concern in all of science, and clearly in neuroscience95,96. Larger
samples are important to addressing this concern, and give greater
hope for important new discoveries in the future.

Some tic patients have been very interested in PANDAS, a name
representing the hypothesis that obsessions, compulsions and tics
represent an aberrant immune response to streptococcal infection
in some children85. Recently a second double-blind study of intravenous immunoglobulin (IVIG) for OCD symptoms in PANDAS
patients was published86. Unfortunately, although effects during
the open label phase were substantial, there was little difference
between the IVIG and control groups during the double-blind portion of the study.
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Supplemental material
Supplementary File 1: Calculation of the percent improvement numbers from the Zhang et al. DBS report81.
Click here to access the data.
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Prof. Kevin Black has provided an up-to-date and largely comprehensive summary of the current status of
our knowledge concerning the phenomenology, natural history, etiology, pathophysiology, and treatment
of Tourette syndrome (TS). However, one important area that is largely missing concerns the findings
from post-mortem studies of the brains of individuals with TS that have been conducted by Flora
Vaccarino and her laboratory at Yale University. The most notable and highly-cited article from 2016
presents an analysis of the transcriptome of striatal tissue (caudate and putamen) from the brains of nine
TS and nine matched normal control subjects (Lennington et al., 20161). The authors found 309
down-regulated and 822 up-regulated genes using a data-driven gene network analysis. More
specifically, they identified 17 gene co-expression modules associated with TS. The top-scoring
down-regulated module in TS was enriched for striatal interneuron transcripts. This finding confirmed
earlier studies by the Vaccarino laboratory that had reported decreased numbers of cholinergic and
gamma-aminobutyric acidergic interneurons in the same brain regions (Kalathini et al., 2005; Kataoka et
al., 20102). However, the top-scoring up-regulated module was enriched in immune-related genes,
consistent with activation of microglia in patients’ striatum. While these findings confirm the earlier
post-mortem studies using unbiased stereological techniques, they also point to the important role of
neuroinflammation in TS pathophysiology. Indeed, a deeper understanding of neuroimmunology may well
transform the field of neuropsychiatry and point to novel treatment approaches to TS and related
disorders (Leckman & Vaccarino, 20153).
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Author Response ( Member of the F1000 Faculty and F1000Research Advisory Board Member ) 12 Sep 2017

Kevin J Black, Department of Psychiatry, Washington University in St Louis, USA
I agree with the importance of the Lennington et al., 2016, paper.1 It is absent from the "from 2016"
highlights article only because (since the final version appeared online before its official publication
date) we discussed it in the 2015 highlights article2 (first paragraph under Pathophysiology). We
cited the Kataoka et al publication3 in the 2014 highlights paper.4 I do appreciate the reference to
the 2015 editorial,5 which together with your review above better highlights the relevance of the
Lennington et al. report to the broader question of neuroimmunology in Tourette syndrome.
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The manuscript submitted by Dr. Black is a very thorough and comprehensive review of the recent
literature on Tourette Syndrome. It is exceptionally well written and organized.
There is one error that needs to be corrected. In the following sentence, there is a missing word and
simply a citation number.
"Another potentially useful approach to TS genetic research was illustrated by 28, who sequenced
candidate genes suggested by previous research in order to identify potential functional variants linked to
TS."
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Other than this, I could find no errors or modifications that I would recommend before publishing this
manuscript.
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Author Response ( Member of the F1000 Faculty and F1000Research Advisory Board Member ) 29 Aug 2017

Kevin J Black, Department of Psychiatry, Washington University in St Louis, USA
Thank you! I can correct the missing author name in a revision after other reviews are back.
Competing Interests: No competing interests were disclosed.

Page 15 of 15

